Position in ALXO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$274,612
+$106,134 QoQ
Shares Held
136,964
-8.1% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,611,306,665 across 416 Biotechnology names. ALXO ranks #303 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $274,612 | 136,964 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $168,478 | 149,097 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $174,142 | 95,160 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $56,402 | 135,909 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $198,227 | 318,183 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $572,918 | 343,066 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $581,929 | 319,742 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,474,641 | 244,551 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,734,112 | 245,212 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,630,776 | 243,840 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $919,315 | 191,524 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,447,191 | 192,702 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $897,477 | 198,557 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,287,031 | 202,931 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,773,068 | 289,767 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,617,885 | 199,986 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,935,426 | 173,694 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,735,068 | 173,805 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $12,900,681 | 174,664 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,352,465 | 171,040 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,981,925 | 176,050 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,348,050 | 120,047 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,370,895 | 115,816 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||